Literature DB >> 21454531

N-acetylaspartylglutamate synthetase II synthesizes N-acetylaspartylglutamylglutamate.

Julia Lodder-Gadaczek1, Ivonne Becker, Volkmar Gieselmann, Lihua Wang-Eckhardt, Matthias Eckhardt.   

Abstract

N-Acetylaspartylglutamate (NAAG) is found at high concentrations in the vertebrate nervous system. NAAG is an agonist at group II metabotropic glutamate receptors. In addition to its role as a neuropeptide, a number of functions have been proposed for NAAG, including a role as a non-excitotoxic transport form of glutamate and a molecular water pump. We recently identified a NAAG synthetase (now renamed NAAG synthetase I, NAAGS-I), encoded by the ribosomal modification protein rimK-like family member B (Rimklb) gene, as a member of the ATP-grasp protein family. We show here that a structurally related protein, encoded by the ribosomal modification protein rimK-like family member A (Rimkla) gene, is another NAAG synthetase (NAAGS-II), which in addition, synthesizes the N-acetylated tripeptide N-acetylaspartylglutamylglutamate (NAAG(2)). In contrast, NAAG(2) synthetase activity was undetectable in cells expressing NAAGS-I. Furthermore, we demonstrate by mass spectrometry the presence of NAAG(2) in murine brain tissue and sciatic nerves. The highest concentrations of both, NAAG(2) and NAAG, were found in sciatic nerves, spinal cord, and the brain stem, in accordance with the expression level of NAAGS-II. To our knowledge the presence of NAAG(2) in the vertebrate nervous system has not been described before. The physiological role of NAAG(2), e.g. whether it acts as a neurotransmitter, remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454531      PMCID: PMC3089511          DOI: 10.1074/jbc.M111.230136

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury.

Authors:  B S Slusher; J J Vornov; A G Thomas; P D Hurn; I Harukuni; A Bhardwaj; R J Traystman; M B Robinson; P Britton; X C Lu; F C Tortella; K M Wozniak; M Yudkoff; B M Potter; P F Jackson
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

2.  N-acetylaspartylglutamate: an endogenous peptide with high affinity for a brain "glutamate" receptor.

Authors:  R Zaczek; K Koller; R Cotter; D Heller; J T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

Review 3.  Evidence that the tri-cellular metabolism of N-acetylaspartate functions as the brain's "operating system": how NAA metabolism supports meaningful intercellular frequency-encoded communications.

Authors:  Morris H Baslow
Journal:  Amino Acids       Date:  2010-06-19       Impact factor: 3.520

Review 4.  N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system.

Authors:  J H Neale; T Bzdega; B Wroblewska
Journal:  J Neurochem       Date:  2000-08       Impact factor: 5.372

Review 5.  Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling.

Authors:  M H Baslow
Journal:  J Neurochem       Date:  2000-08       Impact factor: 5.372

6.  NAAG fails to antagonize synaptic and extrasynaptic NMDA receptors in cerebellar granule neurons.

Authors:  G Losi; S Vicini; J Neale
Journal:  Neuropharmacology       Date:  2004-03       Impact factor: 5.250

7.  Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF.

Authors:  N I Wolf; M A A P Willemsen; U F Engelke; M S van der Knaap; P J W Pouwels; I Harting; J Zschocke; E A Sistermans; D Rating; R A Wevers
Journal:  Neurology       Date:  2004-05-11       Impact factor: 9.910

8.  Biosynthesis of NAAG by an enzyme-mediated process in rat central nervous system neurons and glia.

Authors:  Laura M Gehl; Omar H Saab; Tomasz Bzdega; Barbara Wroblewska; Joseph H Neale
Journal:  J Neurochem       Date:  2004-08       Impact factor: 5.372

9.  Developmental changes of N-acetyl-L-aspartic acid, N-acetyl-alpha-aspartylglutamic acid and beta-citryl-L-glutamic acid in different brain regions and spinal cords of rat and guinea pig.

Authors:  M Miyake; Y Kakimoto
Journal:  J Neurochem       Date:  1981-10       Impact factor: 5.372

10.  N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method.

Authors:  K J Koller; R Zaczek; J T Coyle
Journal:  J Neurochem       Date:  1984-10       Impact factor: 5.372

View more
  11 in total

1.  The pattern of cortical dysfunction in a mouse model of a schizophrenia-related microdeletion.

Authors:  Karine Fénelon; Bin Xu; Cora S Lai; Jun Mukai; Sander Markx; Kimberly L Stark; Pei-Ken Hsu; Wen-Biao Gan; Gerald D Fischbach; Amy B MacDermott; Maria Karayiorgou; Joseph A Gogos
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

2.  ATP-binding Cassette Subfamily C Member 5 (ABCC5) Functions as an Efflux Transporter of Glutamate Conjugates and Analogs.

Authors:  Robert S Jansen; Sunny Mahakena; Marcel de Haas; Piet Borst; Koen van de Wetering
Journal:  J Biol Chem       Date:  2015-10-29       Impact factor: 5.157

Review 3.  Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family.

Authors:  Joseph H Neale; Rafal T Olszewski; Daiying Zuo; Karolina J Janczura; Caterina P Profaci; Kaleen M Lavin; John C Madore; Tomasz Bzdega
Journal:  J Neurochem       Date:  2011-07-01       Impact factor: 5.372

4.  N-acetylaspartylglutamate is an agonist at mGluR₃ in vivo and in vitro.

Authors:  Joseph H Neale
Journal:  J Neurochem       Date:  2011-12       Impact factor: 5.372

Review 5.  The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.

Authors:  James C Evans; Meenakshi Malhotra; John F Cryan; Caitriona M O'Driscoll
Journal:  Br J Pharmacol       Date:  2016-09-23       Impact factor: 8.739

6.  Growth hormone-releasing hormone effects on brain γ-aminobutyric acid levels in mild cognitive impairment and healthy aging.

Authors:  Seth D Friedman; Laura D Baker; Soo Borson; J Eric Jensen; Suzanne M Barsness; Suzanne Craft; George R Merriam; Randolph K Otto; Edward J Novotny; Michael V Vitiello
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

7.  Immunohistological and electrophysiological evidence that N-acetylaspartylglutamate is a co-transmitter at the vertebrate neuromuscular junction.

Authors:  Kathryn K Walder; Steve B Ryan; Tomasz Bzdega; Rafal T Olszewski; Joseph H Neale; Clark A Lindgren
Journal:  Eur J Neurosci       Date:  2012-11-08       Impact factor: 3.386

8.  Evidence of NAAG-family tripeptide NAAG2 in the Drosophila nervous system.

Authors:  Emily M Kozik; Elaine M Marzluff; Clark A Lindgren
Journal:  J Neurochem       Date:  2020-09-21       Impact factor: 5.546

9.  Pediatric Dilated Cardiomyopathy-Associated LRRC10 (Leucine-Rich Repeat-Containing 10) Variant Reveals LRRC10 as an Auxiliary Subunit of Cardiac L-Type Ca2+ Channels.

Authors:  Marites T Woon; Pamela A Long; Louise Reilly; Jared M Evans; Alexis M Keefe; Martin R Lea; Carl J Beglinger; Ravi C Balijepalli; Youngsook Lee; Timothy M Olson; Timothy J Kamp
Journal:  J Am Heart Assoc       Date:  2018-02-03       Impact factor: 5.501

10.  The regulatory role of NAAG-mGluR3 signaling on cortical synaptic plasticity after hypoxic ischemia.

Authors:  Xiaoming Wang; Yang Zheng; Kexin Li; Meng Lu; Mengxu Cui
Journal:  Cell Commun Signal       Date:  2022-04-20       Impact factor: 7.525

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.